This is not the most recent version of the article. View current version (9 DEC 2014)

Intervention Protocol

Vitamin E supplementation in people with cystic fibrosis

  1. Peter O Okebukola1,*,
  2. Sonal Kansra2,
  3. Helen McCabe3

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 9 NOV 2011

Assessed as up-to-date: 20 SEP 2011

DOI: 10.1002/14651858.CD009422


How to Cite

Okebukola PO, Kansra S, McCabe H. Vitamin E supplementation in people with cystic fibrosis (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 11. Art. No.: CD009422. DOI: 10.1002/14651858.CD009422.

Author Information

  1. 1

    Johns Hopkins Bloomberg School of Public Health, Department of Health Policy and Management, Baltimore, Maryland, USA

  2. 2

    Queen's Medical Centre, Department of Child Health, Nottingham, UK

  3. 3

    Royal Victoria Infirmary, Newcastle Upon Tyne, UK

*Peter O Okebukola, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, Maryland, 21205, USA. ookebuko@jhsph.edu. peter.o.okebukola@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 9 NOV 2011

SEARCH

This is not the most recent version of the article. View current version (09 DEC 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the effects of vitamin E supplementation on frequency of vitamin E deficiency disorders.